Global Hemostats Patent Landscape Report 2025

Patent Landscape Report Coverage

The Global Hemostats Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for hemostats include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with Hemostats. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within Hemostats technologies.

Key Inclusions

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for hemostat technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Hemostats.

Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for hemostats and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for hemostats and their relative value in the IP are covered in the final report. 

Hemostats Patent Outlook

• Hemostats are needed in a variety of medical specialities to control bleeding and guarantee patient safety. This need is further driven by minimally invasive procedures and improved surgical techniques.

• The patent landscape is impacted by the rising demand for efficient hemostatic products for managing chronic illnesses like diabetes and cardiovascular diseases, which frequently call for surgical procedures. To ensure successful surgical outcomes, patients with chronic diseases must have their bleeding complications managed.

• Hemostasis is becoming necessary as the world's population ages and age-related health problems make surgery more common. Many elderly patients have complicated medical conditions that necessitate careful bleeding control during procedures.

What are Hemostats?

Hemostats are medical equipment or substances used to reduce or stop bleeding during surgery or following trauma. They function by encouraging blood clotting, bandaging cuts, or physically blocking blood vessels. Hemostats are necessary to minimize blood loss and manage wounds effectively.

The components of hemostats include combination, oxidized regenerated cellulose-based, gelatine-based, and collagen-based hemostats. Hemostats made of oxidized, regenerated cellulose are absorbable materials that originate from cellulose and are chemically altered to improve clotting and bleeding control. Because they can quickly form a gel-like barrier to control bleeding, they are used in various surgical settings.

Hemostats Industry Growth Drivers

Technological Advancement is Expected to Boost the Patent Industry Growth

Hemostat technological developments, such as new materials and enhanced formulations, stimulate market expansion by providing safer and more efficient bleeding control options. Innovations increase the usefulness of products and broaden their application in different surgical contexts. For instance, SURGICEL® FibrillarTM, a hemostatic product from Ethicon Inc., uses cutting-edge technology to achieve hemostasis more quickly. The company's dedication to advancing medical technology in bleeding control is demonstrated by this new formulation, which enhances clot formation through improved cellulose technology. Patents covering these technologies are crucial for companies and thus impact the hemostat patent landscape. There is an increase in patent activity which focuses on enhancing the performance of hemostats. There were 273 patents granted in 2022 which increased to 293 patents by 2023.

Increasing Surgical Procedures is Expected to Propel Hemostats Patent Industry 

The need for efficient hemostatic products is driven by the increase in both the quantity and complexity of surgical procedures. Reliable bleeding control solutions are becoming more and more necessary as surgical procedures increase to guarantee positive results and patient safety.

Hemostats Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product Type

• Combination

• Oxidized Regenerated Cellulose Based

• Gelatine Based

• Collagen Based Hemostat

Analysis by Instrument Type

• Halstead Mosquito Hemostatic Forceps

• Kelly And Crile Hemostatic Forceps

• Rochester-Carmalt Hemostatic Forceps

Analysis by Formulation

• Matrix and Gel Hemostats

• Sheet and Pad Hemostats

• Sponge Hemostats

• Powder Hemostats

Hemostats Patent Segmentation Analysis

The breakup based on product type includes combination, oxidized regenerated cellulose-based, gelatine based, and collagen-based hemostat. Gelatin-based hemostats are sourced from animals, which function by forming a gel that aids in controlling bleeding and encourages quick clotting. Because they are biocompatible and effective, they are frequently utilized in surgeries and are absorbable.

Hemostats Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for hemostats patents, having around 12,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with hemostats patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the hemostats field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Ethicon Inc

A division of Johnson & Johnson, Ethicon Inc. is a leader in cutting-edge surgical supplies, such as hemostats. Started in 1949, the company is based in Cincinnati, Ohio. It is well known for its innovations in wound care and surgical solutions.

Tepha Inc

Headquartered in Lexington, Massachusetts, Tepha Inc. is a developer of medical devices, one of whic...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other companies include Tyco Healthcare, Omrix Biopharmaceuticals Inc, Joshua R&d Technologies LLC, Covidien Lp, Human Genome Sciences Inc, Ecolab Usa Inc, Baxter Int, Cilag Gmbh Int, Boston Scient Scimed Inc, among others.

Reasons to Purchase this Report

The hemostats patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of hemostats.

• Innovation Insights: The patent analysis reveals new innovations and technologies in hemostats.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the hemostat patent landscape.

• Risk Assessment: In technology-intensive fields such as hemostats, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Hemostats Patent Landscape Report

• Who are the key players in the hemostats patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in hemostats patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the hemostats industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in hemostats?
• What are the challenges and opportunities in the hemostats patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in hemostats?

Related Reports

Hemostats Market

General Surgical Devices Market

Minimally Invasive Surgical Devices Market

Surgical Cutting Devices Market